本製品は、現在日本での取り扱いはしておりません。

MiSeqDx

Compare MiSeqDx and MiSeq Systems
Compare MiSeqDx and MiSeq Systems

Each MiSeqDx system delivers comprehensive sequencing solutions to meet the unique needs of both healthcare providers and clinical researchers.


*Report generation is only available for the MiSeqDx Cystic Fibrosis 139-Variant Assay, the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, and the Extended RAS Panel.

540 Mb–15 Gb

output range

12-25 million

reads per run

2 × 300 bp

max read length
Interested in receiving newsletters, case studies, and information from Illumina based on your area of interest? Sign up now.

The MiSeqDx instrument is intended for targeted sequencing of DNA libraries from human genomic DNA extracted from peripheral whole blood or formalin-fixed, paraffin-embedded (FFPE) tissue, when used for in vitro diagnostic (IVD) assays performed on the instrument. The MiSeqDx instrument is not intended for whole genome or de novo sequencing. The MiSeqDx instrument is to be used with registered and listed, cleared, or approved IVD reagents and analytical software.